1. Home
  2. RCEL vs CXDO Comparison

RCEL vs CXDO Comparison

Compare RCEL & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • CXDO
  • Stock Information
  • Founded
  • RCEL N/A
  • CXDO 1995
  • Country
  • RCEL United States
  • CXDO United States
  • Employees
  • RCEL N/A
  • CXDO N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • CXDO Telecommunications Equipment
  • Sector
  • RCEL Health Care
  • CXDO Telecommunications
  • Exchange
  • RCEL Nasdaq
  • CXDO Nasdaq
  • Market Cap
  • RCEL 161.5M
  • CXDO 169.5M
  • IPO Year
  • RCEL N/A
  • CXDO 1998
  • Fundamental
  • Price
  • RCEL $5.19
  • CXDO $5.25
  • Analyst Decision
  • RCEL Strong Buy
  • CXDO Strong Buy
  • Analyst Count
  • RCEL 4
  • CXDO 2
  • Target Price
  • RCEL $16.50
  • CXDO $8.75
  • AVG Volume (30 Days)
  • RCEL 287.8K
  • CXDO 210.2K
  • Earning Date
  • RCEL 08-07-2025
  • CXDO 08-05-2025
  • Dividend Yield
  • RCEL N/A
  • CXDO N/A
  • EPS Growth
  • RCEL N/A
  • CXDO 51.44
  • EPS
  • RCEL N/A
  • CXDO 0.09
  • Revenue
  • RCEL $71,661,000.00
  • CXDO $62,609,000.00
  • Revenue This Year
  • RCEL $57.29
  • CXDO $12.98
  • Revenue Next Year
  • RCEL $28.07
  • CXDO $10.91
  • P/E Ratio
  • RCEL N/A
  • CXDO $58.78
  • Revenue Growth
  • RCEL 41.35
  • CXDO 13.85
  • 52 Week Low
  • RCEL $5.10
  • CXDO $2.92
  • 52 Week High
  • RCEL $14.16
  • CXDO $7.34
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 29.07
  • CXDO 48.35
  • Support Level
  • RCEL $5.10
  • CXDO $5.21
  • Resistance Level
  • RCEL $6.33
  • CXDO $5.49
  • Average True Range (ATR)
  • RCEL 0.32
  • CXDO 0.18
  • MACD
  • RCEL 0.02
  • CXDO -0.04
  • Stochastic Oscillator
  • RCEL 6.10
  • CXDO 32.88

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

Share on Social Networks: